Catabasis Pharmaceuticals, Inc. logo
Catabasis Pharmaceuticals, Inc. CATB

Catabasis Pharmaceuticals, Inc. Revenue | CATB

Company revenue is the total amount of money received from the sale of goods or services over a certain period of time. It is one of the key indicators of a company's financial condition and success.

Traditionally defined as follows:
Revenue = Price * Quantity of products

Revenue is one of the components of a company’s income. In international practice, revenue is understood as the inflow or other increase in a company's assets or the settlement of its obligations that occurs as a result of the company’s core or main activity.[1]

This is an important indicator for assessing the financial condition and efficiency of a company. It makes it possible to determine how successfully a company sells its products or services on the market. In addition, revenue can be used to calculate other financial indicators such as profit, profitability, and market share.

Various factors can influence this indicator, including demand for goods or services, market competition, economic conditions, and the company's marketing efforts. Therefore, its analysis and monitoring are important tasks for the successful development of a business.

Annual Revenue Catabasis Pharmaceuticals, Inc.

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - - 500 K - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
500 K 500 K 500 K

References

  1. Adhikari, B. (2010). Impact of Revenue Planning In Nepal Investment Bank Limited (Doctoral dissertation, Faculty of Management).

Revenue of other stocks in the Biotechnology industry

Issuer Revenue Price % 24h Market Cap Country
Pharming Group N.V. Pharming Group N.V.
PHAR
186 M $ 12.48 3.51 % $ 8.6 B niderlandNiderland
Capricor Therapeutics Capricor Therapeutics
CAPR
22.3 M $ 8.04 -4.4 % $ 374 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
720 M $ 29.66 1.91 % $ 1.39 B usaUSA
Dr. Reddy's Laboratories Limited Dr. Reddy's Laboratories Limited
RDY
326 B $ 14.98 1.28 % $ 12.5 B indiaIndia
China Biologic Products Holdings, Inc. China Biologic Products Holdings, Inc.
CBPO
524 M - 1.68 % $ 4.65 B chinaChina
Regeneron Pharmaceuticals Regeneron Pharmaceuticals
REGN
14.3 B $ 945.14 -1.32 % $ 98.9 B usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
44.5 M $ 3.78 2.16 % $ 404 M usaUSA
Jaguar Health Jaguar Health
JAGX
11.5 M $ 0.35 -8.69 % $ 816 K usaUSA
Arvinas Arvinas
ARVN
263 M $ 6.77 -0.73 % $ 480 M usaUSA
Cerus Corporation Cerus Corporation
CERS
234 M $ 1.95 2.63 % $ 372 M usaUSA
Beam Therapeutics Beam Therapeutics
BEAM
140 M $ 21.03 1.82 % $ 2.08 B usaUSA
Inhibrx Inhibrx
INBX
1.8 M $ 68.87 -7.16 % $ 3.25 B usaUSA
Royalty Pharma plc Royalty Pharma plc
RPRX
2.38 B $ 68.76 0.12 % $ 29.6 B usaUSA
Entera Bio Ltd. Entera Bio Ltd.
ENTX
42 K $ 3.24 8.0 % $ 150 M israelIsrael
Revolution Medicines Revolution Medicines
RVMD
11.6 M $ 159.7 -1.84 % $ 30.4 B usaUSA
Flexion Therapeutics, Inc. Flexion Therapeutics, Inc.
FLXN
85.6 M - - $ 459 M usaUSA
Legend Biotech Corporation Legend Biotech Corporation
LEGN
627 M $ 16.25 0.87 % $ 5.99 B usaUSA
CytomX Therapeutics CytomX Therapeutics
CTMX
76.2 M $ 1.91 -1.55 % $ 263 M usaUSA
Krystal Biotech Krystal Biotech
KRYS
389 M $ 314.77 5.43 % $ 9.11 B usaUSA
Kura Oncology Kura Oncology
KURA
67.5 M $ 7.34 -2.07 % $ 644 M usaUSA
Inhibikase Therapeutics Inhibikase Therapeutics
IKT
261 K $ 1.39 0.36 % $ 137 M usaUSA
Phathom Pharmaceuticals Phathom Pharmaceuticals
PHAT
175 M $ 5.31 -3.45 % $ 387 M usaUSA
Heron Therapeutics Heron Therapeutics
HRTX
155 M $ 0.27 -3.26 % $ 45 M usaUSA
Inovio Pharmaceuticals Inovio Pharmaceuticals
INO
65.3 K $ 1.69 3.37 % $ 79.2 M usaUSA
SIGA Technologies SIGA Technologies
SIGA
94.6 M $ 2.81 2.75 % $ 201 M usaUSA
Aytu BioScience Aytu BioScience
AYTU
57.6 M $ 2.66 -0.19 % $ 32.8 M usaUSA
Heat Biologics, Inc. Heat Biologics, Inc.
HTBX
2.95 M - -5.76 % $ 99.8 M usaUSA
Innoviva Innoviva
INVA
411 M $ 18.36 0.3 % $ 1.24 B usaUSA
BioCardia BioCardia
BCDA
58 K $ 0.77 -2.06 % $ 5.13 M usaUSA
Kindred Biosciences, Inc. Kindred Biosciences, Inc.
KIN
42.2 M - 0.11 % $ 419 M usaUSA
Syndax Pharmaceuticals Syndax Pharmaceuticals
SNDX
172 M $ 8.55 -7.07 % $ 741 M usaUSA
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
109 K $ 1.72 -7.77 % $ 11 B australiaAustralia
Shineco, Inc. Shineco, Inc.
TYHT
23.7 M - -3.90 % $ 97.2 M chinaChina
Oramed Pharmaceuticals Oramed Pharmaceuticals
ORMP
2 M $ 3.9 0.78 % $ 161 M israelIsrael
Certara Certara
CERT
419 M $ 11.25 1.72 % $ 1.8 B usaUSA
PainReform Ltd. PainReform Ltd.
PRFX
17 K $ 0.63 -4.8 % $ 408 K israelIsrael
Anika Therapeutics Anika Therapeutics
ANIK
113 M $ 13.74 6.89 % $ 197 M usaUSA
Prothena Corporation plc Prothena Corporation plc
PRTA
9.68 M $ 8.38 1.39 % $ 451 M usaUSA
Processa Pharmaceuticals Processa Pharmaceuticals
PCSA
5 K $ 1.7 -2.3 % $ 2.23 M usaUSA
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
CORT
761 M $ 67.94 -3.04 % $ 7.06 B usaUSA
Progenity, Inc. Progenity, Inc.
PROG
74.3 M - -3.47 % $ 164 M usaUSA
China SXT Pharmaceuticals China SXT Pharmaceuticals
SXTC
1.14 M $ 2.84 -0.7 % $ 1.93 M chinaChina